ADMA Biologics vs. Grifols: Which Plasma Therapy Stock Is the Better Buy?

• click to rate

  Posted by Two Blokes May 28, 2025 - Filed in Stock - 9 views
  
  At current levels, GRFS scores over ADMA with cheaper valuation, a broad portfolio, and strong EPS growth estimates despite the latter's robust Asceniv-driven momentum.